The Duchenne Muscular Dystrophy (DMD) therapeutics market is booming, projected to reach $1237.8 million by 2025, with a CAGR of 40.3%. Discover key drivers, trends, and challenges shaping this rapidly evolving landscape, including innovative gene therapies and the role of leading pharmaceutical companies.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
